• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎相关肝细胞癌患者的长期生存及影响因素:一项真实世界研究。

Long-Term Survival and Risk Factors in Patients with Hepatitis B-Related Hepatocellular Carcinoma: A Real-World Study.

机构信息

Department of Hepatopancreatobiliary Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou 317000, China.

Division of Liver Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.

出版信息

Can J Gastroenterol Hepatol. 2022 Aug 23;2022:7750140. doi: 10.1155/2022/7750140. eCollection 2022.

DOI:10.1155/2022/7750140
PMID:36051249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9427325/
Abstract

A retrospective cohort study was conducted to collect 465 patients with hepatitis B-related hepatocellular carcinoma who had undergone radical hepatectomy from January 1, 2012, to August 31, 2018, at the First Affiliated Hospital of the University of Science and Technology of China. The clinical, pathological, and follow-up information was collected to compare the basic characteristics of death and nondeath after radical resection. Kaplan-Meier curves were used for survival analysis and male and female subgroup analysis. The multivariate Cox proportional-hazards regression model was used to analyze independent risk factors related to postoperative death. Of the 465 patients with radical resection of hepatitis B-related hepatocellular carcinoma, 132 died, and 1-, 3-, and 5-year cumulative survival rates after operation were 92.1%, 78%, and 64%, respectively. In the male and female subgroup, 115 and 17 patients died, respectively. The 1-, 3-, and 5-year cumulative survival rates were 92.6%, 77.0%, and 62.6%, respectively, in men, and 89.6%, 78.8%, and 70.2%, respectively, in women. Multivariate Cox proportional-hazards regression analysis showed that microvascular invasion (MVI), Edmondson III/IV, BCLC stage B, and total bilirubin (TB) > 20.5 mol/L were independent risk factors in patients with hepatitis B-related hepatocellular carcinoma after radical hepatectomy.

摘要

一项回顾性队列研究收集了 2012 年 1 月 1 日至 2018 年 8 月 31 日期间在科技大学第一附属医院接受根治性肝切除术的 465 例乙型肝炎相关肝细胞癌患者的临床、病理和随访信息,以比较根治性切除术后死亡和非死亡患者的基本特征。采用 Kaplan-Meier 曲线进行生存分析和男女亚组分析。采用多变量 Cox 比例风险回归模型分析与术后死亡相关的独立危险因素。在接受根治性乙型肝炎相关肝细胞癌切除术的 465 例患者中,有 132 例死亡,术后 1、3 和 5 年累积生存率分别为 92.1%、78%和 64%。在男性和女性亚组中,分别有 115 例和 17 例死亡,男性患者的 1、3 和 5 年累积生存率分别为 92.6%、77.0%和 62.6%,女性患者分别为 89.6%、78.8%和 70.2%。多变量 Cox 比例风险回归分析显示,微血管侵犯(MVI)、Edmondson III/IV 级、BCLC 分期 B 和总胆红素(TB)>20.5μmol/L 是乙型肝炎相关肝细胞癌根治性肝切除术后的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/1d16fb77bb25/CJGH2022-7750140.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/87263fce70a8/CJGH2022-7750140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/847a42276bdb/CJGH2022-7750140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/1d16fb77bb25/CJGH2022-7750140.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/87263fce70a8/CJGH2022-7750140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/847a42276bdb/CJGH2022-7750140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0964/9427325/1d16fb77bb25/CJGH2022-7750140.003.jpg

相似文献

1
Long-Term Survival and Risk Factors in Patients with Hepatitis B-Related Hepatocellular Carcinoma: A Real-World Study.慢性乙型肝炎相关肝细胞癌患者的长期生存及影响因素:一项真实世界研究。
Can J Gastroenterol Hepatol. 2022 Aug 23;2022:7750140. doi: 10.1155/2022/7750140. eCollection 2022.
2
A nomogram model for early recurrence of HBV-related hepatocellular carcinomas after radical hepatectomy.根治性肝切除术后乙型肝炎病毒相关肝细胞癌早期复发的列线图模型。
Front Endocrinol (Lausanne). 2024 Sep 2;15:1374245. doi: 10.3389/fendo.2024.1374245. eCollection 2024.
3
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.术后辅助经导管动脉化疗栓塞治疗伴微血管侵犯的肝细胞癌患者的疗效。
World J Gastroenterol. 2017 Nov 7;23(41):7415-7424. doi: 10.3748/wjg.v23.i41.7415.
4
[Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].[不同中国肝癌分期肝细胞癌患者根治性肝切除术后的临床疗效及预后因素分析]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):134-143. doi: 10.3760/cma.j.cn112139-20200803-00605.
5
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.经导管动脉化疗栓塞术对肝细胞癌术后辅助治疗的临床疗效
World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.
6
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
7
Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.埃德蒙森-施泰纳分级:无微血管侵犯的肝细胞癌复发和生存的关键预测指标。
Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.
8
The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.早期-中期肝细胞癌中微血管侵犯的预后价值:倾向评分匹配分析。
BMC Cancer. 2018 Mar 12;18(1):278. doi: 10.1186/s12885-018-4196-x.
9
Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.切除术后肝细胞癌患者微血管侵犯新风险分类的预后价值
Oncotarget. 2017 Jan 17;8(3):5474-5486. doi: 10.18632/oncotarget.12547.
10
Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.巴塞罗那临床肝癌分期 B 期肝癌行肝切除术的生存结局。
World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.

引用本文的文献

1
A nomogram model for early recurrence of HBV-related hepatocellular carcinomas after radical hepatectomy.根治性肝切除术后乙型肝炎病毒相关肝细胞癌早期复发的列线图模型。
Front Endocrinol (Lausanne). 2024 Sep 2;15:1374245. doi: 10.3389/fendo.2024.1374245. eCollection 2024.
2
Surgical resection for hepatocellular carcinoma: a single-centre's one decade of experience.肝细胞癌的手术切除:单中心十年经验
Ann Med Surg (Lond). 2024 Feb 8;86(3):1289-1296. doi: 10.1097/MS9.0000000000001746. eCollection 2024 Mar.
3
[Overexpression of CLEC5A inhibits cell proliferation and metastasis and reverses epithelial-mesenchymal transition in hepatocellular carcinoma].

本文引用的文献

1
High expression of associated with progression and poor prognosis of hepatocellular carcinoma.高表达与肝细胞癌的进展和不良预后相关。
Scand J Gastroenterol. 2021 Nov;56(11):1349-1354. doi: 10.1080/00365521.2021.1961305. Epub 2021 Aug 15.
2
Radiomics analysis of [F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma.基于[F]FDG PET/CT 的影像组学分析对极早期和早期肝细胞癌微血管侵犯及预后预测的价值
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2599-2614. doi: 10.1007/s00259-020-05119-9. Epub 2021 Jan 8.
3
Expression of Pregnancy Up-regulated Non-ubiquitous Calmodulin Kinase (PNCK) in Hepatocellular Carcinoma.
[CLEC5A过表达抑制肝癌细胞增殖和转移并逆转上皮-间质转化]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):85-91. doi: 10.12122/j.issn.1673-4254.2023.01.11.
在肝癌中表达妊娠上调非普遍钙调蛋白激酶 (PNCK)。
Cancer Genomics Proteomics. 2020 Nov-Dec;17(6):747-755. doi: 10.21873/cgp.20229.
4
Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.基于 XGBoost 和深度学习的肝细胞癌微血管侵犯术前预测。
J Cancer Res Clin Oncol. 2021 Mar;147(3):821-833. doi: 10.1007/s00432-020-03366-9. Epub 2020 Aug 27.
5
Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients.PD-L1与SOCS3共表达与肝细胞癌患者预后的相关性
J Cancer. 2020 Jul 11;11(18):5440-5448. doi: 10.7150/jca.46158. eCollection 2020.
6
A Novel Prognostic Scoring Model Based on Albumin and γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis.一种基于白蛋白和γ-谷氨酰转移酶的新型肝细胞癌预后评分模型
Cancer Manag Res. 2019 Dec 23;11:10685-10694. doi: 10.2147/CMAR.S232073. eCollection 2019.
7
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
Laparoscopic combined with thoracoscopic transdiaphragmatic hepatectomy for hepatitis B-related hepatocellular carcinoma located in segment VII or VIII.腹腔镜联合胸腔镜经膈肌肝切除术治疗位于Ⅶ或Ⅷ段的乙型肝炎相关肝细胞癌
Hepatobiliary Pancreat Dis Int. 2020 Jun;19(3):291-294. doi: 10.1016/j.hbpd.2019.11.002. Epub 2019 Dec 4.
9
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies.BRAF在肝细胞癌中的作用:未来靶向癌症治疗的理论依据。
Medicina (Kaunas). 2019 Nov 21;55(12):754. doi: 10.3390/medicina55120754.
10
A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance.单叶肝细胞癌无肉眼血管侵犯患者肝切除术后早期肝内复发的简化预测模型:辅助治疗和术后监测的意义。
Surg Oncol. 2019 Sep;30:6-12. doi: 10.1016/j.suronc.2019.05.017. Epub 2019 May 22.